| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 18.257 | 56.304 | 61.511 | 60.562 | 65.649 | 66.775 |
| Total Income - EUR | - | - | - | 0 | 18.257 | 56.306 | 61.536 | 60.562 | 65.649 | 66.775 |
| Total Expenses - EUR | - | - | - | 173 | 10.411 | 31.909 | 38.734 | 36.309 | 32.010 | 22.527 |
| Gross Profit/Loss - EUR | - | - | - | -173 | 7.846 | 24.396 | 22.802 | 24.253 | 33.639 | 44.248 |
| Net Profit/Loss - EUR | - | - | - | -173 | 7.663 | 23.876 | 22.198 | 23.660 | 32.996 | 42.285 |
| Employees | - | - | - | 0 | 1 | 1 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Iridomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 24 | 0 | 27.169 | 26.101 | 26.182 | 26.103 | 25.957 |
| Current Assets | - | - | - | 215 | 8.845 | 18.189 | 16.165 | 76.669 | 26.972 | 26.788 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 223 | 322 | 2.802 | 63.058 | 2.927 | 2.695 |
| Cash | - | - | - | 0 | 8.622 | 17.866 | 13.364 | 13.611 | 24.046 | 24.092 |
| Shareholders Funds | - | - | - | 42 | 7.705 | 24.124 | 22.441 | 23.903 | 33.238 | 42.526 |
| Social Capital | - | - | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | 197 | 1.140 | 21.270 | 19.825 | 78.948 | 19.837 | 10.219 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Iridomed S.r.l.